Noninfectious sinusitis

Allergy and Clinical Immunology International

Volumn 13, Issue 1, 2001, Pages 27-32

  Hamilos, D L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BACTERIAL ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; FLUTICASONE; INTERLEUKIN 5; PLACEBO; STEROID;

ALLERGIC DISEASE; ARTICLE; ASTHMA; BACTERIAL INFECTION; CELL INFILTRATION; CHRONIC SINUSITIS; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOUBLE BLIND PROCEDURE; EOSINOPHIL; EOSINOPHILIA; FUNGUS; HISTOCHEMISTRY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IN SITU HYBRIDIZATION; INFLAMMATION; INFLAMMATORY CELL; MONONUCLEAR CELL; MUCOSA INFLAMMATION; NOSE POLYP; T LYMPHOCYTE;

EID: 0035110897     PISSN: 08381925     EISSN: None     Source Type: Journal    
DOI: 10.1027/0838-1925.13.1.27     Document Type: Article

References (59)

1. The National Health Interview Survey, 1994
2. Epidemiology of nasal polyps
3. Sinusitis: Bench to bedside
4. The role of cytokines in infectious sinusitis and nasal polyposis
5. Sinus mucosal interleukin-8 gene expression in chronic rhinosinusitis
6. Chronic hyperplastic sinusitis: Association of tissue eosinophilia with mRNA expression of granulocyte-macrophage colony-stimulating factor and interleukin-3
7. Sinusitis in adults and its relation to allergic rhinitis, asthma, and nasal polyps
8. A clinical and pathologic study of chronic sinusitis: The role of the eosinophil
9. Distribution of mast cells and eosinophils in nasal polyps from atopic and nonatopic subjects: A morphometric study
10. Activated and non-activated eosinophils in patients with chronic rhinosinusitis
11. Hemopoietic function of the microenvironment in chronic airway inflammation
12. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis
13. Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-α
14. GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP)
15. Increases in activated T lymphocytes, eosinophils, and cytokine mRNA expression for interleukin-5 and granulocyte/macrophage colony-stimulating factor in bronchial biopsies after allergen inhalation challenge in atopic asthmatics
16. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage
17. Expression of mRNA and immunoreactivity for the granulocyte/macrophage colony-stimulating factor in activated human eosinophils
18. Accumulation of interferon γ-producing TH1 helper T cells in nasal polyps
19. T lymphocytes that infiltrate nasal polyps have a specialized phenotype and produce a mixed Th1/Th2 pattern of cytokines
20. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia
21. Mechanisms of eosinophil adherence to cultured vascular endothelial cells. Eosinophils bind to the cytokine-induced endothelial ligand vascular adhesion-1 via the very late activation antigen-4 integrin receptor
22. Adhesion of human basophils, eosinophils, and neutrophils to interleukin1-activated human vascular endothelial cells: Contribution of endothelial cell adhesion molecules
23. Tumor necrosis factor combines with IL-4 or IFN-γ to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms
24. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis
25. Interleukin-8 gene expression in chronic sinusitis
26. Differential in situ cytokine gene expression in acute chronic atopic dermatitis
27. Biphasic response against aeroallergen in atopic dermatitis showing a switch from an initial Th2 response to a Th1 response in situ: An immunocytochemical study
28. Role of T cells in atopic dermatitis. New aspects on the dynamics of cytokine production and the contribution of bacterial superantigens
29. Allergen specificity of skin-infiltrating T cells is not restricted to a type-2 cytokine pattern in chronic skin lesions of atopic dermatitis
30. Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: Implications for cystic fibrosis
31. Pseudomonas stimulates interleukin-8 mRNA expression selectively in airway epithelium, in gland ducts, and in recruited neutrophils
32. Bacterial-induced release of inflammatory mediators by bronchial epithelial cells
33. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-γ)
34. Interleukin-6 expression in chronic sinusitis: Colocalization of gene transcripts to eosinophils, macrophages, T lymphocytes, and mast cells
35. Positive identification in situ of mRNA expression of IL-6, and IL-12, and the chemotactic cytokine RANTES in patients with chronic sinusitis and polypoid disease
36. Bacterial allergy in nasal polyposis. A new method for quantifying specific IgE
37. Diagnostic criteria for allergic fungal sinusitis
38. Allergic fungal sinusitis: The Mayo Clinic Experience
39. Effect of intranasal fluticasone on cellular infiltration, endothelial adhesion molecule expression and proinflammatory cytokine mRNA in nasal polyp disease
40. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte-macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: Relationship to tissue eosinophilia
41. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge
42. A dose-ranging study of fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis assessed by symptoms, rhinomanometry, and nasal cytology
43. GM-CSF, IL-5 and RANTES immunoreactivity and mRNA expression in chronic hyperplastic sinusitis with nasal polyposis (NP)
44. Expression of IL-4, Cd RNA, and Ie RNA in the nasal mucosa of patients with seasonal rhinitis: Effect of topical corticosteroids
45. Steroid-resistant asthma: Immunologic and pharmacologic features
46. Glucocorticoid resistance in chronic asthma: Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T-cell proliferation by glucocorticoids in vitro
47. Clucocorticoid resistance in chronic asthma: Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoid and cyclosporin A
48. Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy
49. Steroid resistance in asthma. Molecular mechanism
50. Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma
51. Abnormal glucocorticoid receptor/AP-1 interaction in steroid-resistant asthma
52. Glucocorticoid receptor β, a potential endogenous inhibitor of glucocorticoid action in humans
53. The human glucocorticoid receptor β isoform. Expression, biochemical properties, and putative function
54. Syndromes of glucocorticoid and mineralocorticoid resistance
55. Association of glucocorticoid insensitivity with increased expression of glucocorticoid receptor β
56. Expression of GRβ in nasal polyps (NP) and its relationship to glucocorticoid responsiveness
57. The combined effects of IL-2 and IL-4 alter the binding affinity of the glucocorticoid receptor
58. A novel action of IL-13. Induction of diminished monocyte glucocorticoid receptor-binding affinity
59. Nasal polyps - A model of chronic respiratory mucosal inflammation